Subscriber access provided by UNIV OF LOUISIANA
Bioactive Constituents, Metabolites, and Functions
The fucoidan A2 from the brown seaweed Ascophyllum nodosum lowers lipid by improving reverse cholesterol transport in C57BL/6J mice fed a high-fat diet Zixun Yang, Guanjun Liu, Jiayu Yin, Yufeng Wang, Jin Wang, Bin Xia, Ting Li, Xiaoqian Yang, Pengbo Hou, Shumei Hu, Weiguo Song, and Shoudong Guo J. Agric. Food Chem., Just Accepted Manuscript • Publication Date (Web): 04 May 2019 Downloaded from http://pubs.acs.org on May 6, 2019
Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.
is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.
Page 1 of 35
Journal of Agricultural and Food Chemistry
1
The fucoidan A2 from the brown seaweed Ascophyllum nodosum lowers lipid by
2
improving reverse cholesterol transport in C57BL/6J mice fed a high-fat diet
3
Zixun Yanga#, Guanjun Liub#, Yufeng Wangc#, Jiayu Yina, Jin Wanga, Bin Xiaa, Ting
4
Lia, Xiaoqian Yanga, Pengbo Houa, Shumei Hua, Weiguo Songa*, Shoudong Guoa*
5
aInstitute
6
School of Pharmacy, Weifang Medical University, Weifang, 261053, China
7
bWeihai
8
cNanjing
9
#Contribute
of Lipid Metabolism and Atherosclerosis, Innovative Drug Research Centre,
Municipal Hospital, Weihai, 264200, China Well Pharmaceutical Co., Ltd. Nanjing, 210042, China equally to this article.
10 11
*Corresponding author
12
Shoudong Guo, Address: 7166# Baotong West Street, Weifang, Shandong Province,
13
China. E-mail:
[email protected]; Tel: +86 0536 8462014. This article may
14
also correspond to Weiguo Song, E-mail:
[email protected]; Tel: +86 0536
15
8462014.
16 17 18 19 20 1
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
21
ABSTRACT: Reverse cholesterol transport (RCT) is a physiological process in
22
which excess peripheral cholesterol is transported to the liver, and further excreted
23
into the bile and then feces. Recently, fucoidans are reported to have lipid-lowering
24
effect. This study was designed to investigate whether the fucoidan from the brown
25
seaweed A. nodosum lowers lipid by modulating RCT in C57 BL/6J mice fed a high-
26
fat diet. Our results indicated that fucoidan intervention significantly reduced plasma
27
triglyceride, TC and fat pad index, and markedly increased HDL-C in a dose-
28
dependent manner. In the liver, the fucoidan significantly increased the expression of
29
PPARα and γ, LXRβ, ABCA1, ABCG8, LDLR, SR-B1 and CYP7A1; and decreased
30
triglyceride level and expression of PCSK9 and PPARβ; but had no effect on LXRα,
31
ABCG1 and ABCG5. In the small intestine, the fucoidan treatment significantly
32
reduced the expression of NPC1L1 and improved ABCG5/8. These results
33
demonstrated that the fucoidan can improve lipids transfer from plasma to the liver by
34
activating SR-B1 and LDLR and inactivating PCSK9; and up-regulate lipid
35
metabolism by activating PPARα, LXRβ, ABC transporters and CYP7A1. In the
36
small intestine, this fucoidan can decrease cholesterol absorption and increase
37
cholesterol excretion by activating NPC1L1 and ABCG5/8, respectively. In
38
conclusion, the fucoidan from A. nodosum may lower lipids by modulating RCT-
39
related protein expression, and it can be explored as a potential compound for
40
prevention or treatment of hyperlipidemia-related diseases.
41 42
Keywords: PPAR agonist; cholesterol metabolism; NPC1L1; ABC transporter
43
2
ACS Paragon Plus Environment
Page 2 of 35
Page 3 of 35
Journal of Agricultural and Food Chemistry
44
INTRODUCTION
45
Cardiovascular diseases (CVDs) are the major cause of mortality worldwide, and
46
lipid-lowering drugs like statins are shown to have side effects.1 Therefore, natural
47
products with lower toxicity and powerful hypolipidemic effect have attracted
48
researchers’ attentions. Fucoidans are water-soluble, negative charged polysaccharide
49
found in great abundance in brown seaweed and sea cucumber.2,3 They possess
50
various biological functions as investigated both in vitro and in vivo.4-10
51
Based on the previous studies, fucoidan is a potential candidate for lipid-lowering.
52
For example, the fucoidan polysaccharide from brown seaweed can significantly
53
reduce the serum total cholesterol (TC), triglyceride (TG) and low-density lipoprotein
54
cholesterol (LDL-C), increase the high-density lipoprotein cholesterol (HDL-C) and
55
the activity of lipoprotein lipase, hepatic lipoprotein and lecithin cholesterol
56
acyltransferase in high-fat diet rats, C57 BL/6NtacSam mice and apolipoprotein E-
57
deficient mice.11-13 The fucoidan from the sea cucumber can reduce TC, LDL-C and
58
fat tissue weight in mice fed a high-fat diet.14,15 What’s more, fucoidan administration
59
significantly reduces LDL-C in obese adults.16
60
Several studies have partially demonstrated the mechanism of fucoidan on lipid-
61
lowering. For instance, the fucoidan from brown seaweed Fucus vesiculosus (family
62
Fucaceae) can up-regulate liver low-density lipoprotein receptor (LDLR) and down-
63
regulate sterol regulatory element-binding protein (SREBP) 2 in poloxamer-407-
64
induced hyperlipidemic mice;12 the fucoidan from Cladosiphon okamuranus can
65
activate the mRNA expression of peroxisome proliferator-activated receptor (PPAR)
66
α and inactivate the mRNA expression of SREBP1 in apolipoprotein E-deficient
67
mice;13 and the fucoidan from sea cucumber Acaudina molpadioides may modulate 3
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
Page 4 of 35
68
the Wnt/β-catenin pathway and down-regulate the SREBP-1c expression in mice fed a
69
high-fat diet.14 However, the underlying mechanism of fucoidan on lipid-lowering is
70
still far from clarification.
71
Reverse cholesterol transport (RCT) is a physiological process in which excess
72
peripheral cholesterol is transported by high-density lipoprotein (HDL) or non-HDL
73
to the liver, and further excreted into the bile and then feces.17,18 In the plasma, ATP
74
binding cassette (ABC) A1 and G1 mediate the transfer of peripheral cholesterol and
75
cholesterol ester to apolipoprotein (apo) A1 and HDL, respectively. The plasma lipids
76
carried by HDL and non-HDL can be transported to the liver by scavenger receptor B
77
type 1 (SR-B1) and LDLR, respectively. Furthermore, proprotein convertase
78
subtilisin/kexin type 9 (PCSK9) binds to the epidermal growth factor-like repeat A
79
domain of the LDLR and induces LDLR degradation. In the liver, PPARs regulate a
80
network of genes involved in lipid metabolism, and the activation of PPARα and β
81
can accelerate lipid utilization and the activation of PPARγ can induce fat storage. On
82
the one hand, lipids in the liver can be excreted by ABC transporters such as, ABCG5
83
and ABCG8, which are regulated by Liver X receptor (LXR)s; on the other hand,
84
cholesterol can be transformed to bile acid by enzymes such as, cholesterol 7 alpha-
85
hydroxylase A1 (CYP7A1) which is also a target gene of LXRs. In the small intestine,
86
Niemann-Pick C1-like 1 (NPC1L1) is responsible for the uptake of cholesterol
87
molecules from the gut lumen and bile, whereas ABCG5 and ABCG8 are responsible
88
for
89
hyperlipidemia.17,18 To our best knowledge, we report for the first time that fucoidan
90
from A. nodosum lowers lipid by improving the RCT-related protein expression, and
91
especially via modulating the cholesterol absorption and excretion in the small
92
intestine of the C57 BL/6J mice fed high-fat diet.
the
cholesterol
excretion.
Therefore,
RCT
4
ACS Paragon Plus Environment
is
believed
to
facilitate
Page 5 of 35
Journal of Agricultural and Food Chemistry
93
MATERIALS AND METHODS
94
Materials
95
The brown seaweed Ascophyllum nodosum was collected at Saint Lawrence River in
96
Quebec, Canada. The croud fucoidan was prepared and given as a gift by Weihai
97
Rensheng Pharmaceutical Group Co.,Ltd. Q-sepharoseTM Fast Flow and Sephacryl
98
S200HR were the products of GE healthcare (Piscataway, NJ, USA). Monosaccharide
99
standards (L-rhamnose, L-fucose, D-xylose, D-mannose, D-galactose, D-glucose, D-
100
glucuronic acid and D-glucosamine), dextran standards (Mw: 11.6, 23.8, 48.6, 147.6,
101
409.8, 1100.0 and 2000 kDa) and 1-phenyl-3-methyl-5-pyrazolone (PMP) were from
102
Sigma-Aldrich (St. Louis, MO, USA). Fenofibrate (S1794) was the product of Selleck
103
(Shanghai, China). RIPA lysis buffer was a product of Merck (3108491, Darmstadt,
104
Germany). Rabbit polyclonal antibody against LDLR (ab30532, 1:500, Mw 95 kDa),
105
LXRα (ab3585, 1:200, Mw 50 kDa) and LXRβ (ab28479, 1:500, Mw 51 kDa); rabbit
106
monoclonal antibody against SR-B1 (ab217318, 1:1000, Mw 80 kDa), ABCG1
107
(ab52617, 1:1000, Mw 110 kDa) and mouse monoclonal antibody against ABCA1
108
(ab18180, 1:200, Mw 254 kDa) were from Abcam (Cambridge, MA, USA). Mouse
109
monoclonal antibody against NPC1L1 (sc-166802, 1:200, Mw 142-148 kDa), and
110
peroxisome proliferator-activated receptor (PPAR) α (sc-398394, 1:100, Mw 55 kDa),
111
PPARβ (sc-74517, 1:100, Mw 55 kDa) and PPARγ (sc-7273, 1:100, Mw 55 kDa)
112
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Mouse
113
monoclonal antibody against β-actin (66009-1-Ig, 1:5000, Mw 43 kDa), rabbit
114
monoclonal antibody against PCSK9 (55206-1-AP, 1:500, Mw 71 kDa) and rabbit
115
polyclonal antibody against ABCG5 (27722-1-AP, 1:1000, Mw 72 kDa) were the
116
products of Proteintech (Chicago, IL, USA). Mouse monoclonal antibody against 5
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
117
ABCG8 (1B10A5, 1:1000, Mw 76 kDa) and enhanced chemiluminescence (ECL) kits
118
were purchased from Thermo Scientific Pierce (Rockford, IL, USA). Rabbit
119
polyclonal antibody against CYP7A1 (TA351400, 1:1000, Mw 58 kDa) was the
120
product of OriGene (Shanghai, China). Complete protease inhibitor, the secondary
121
antibodies and the BCA protein assay kits (CW0014S) were from CWBIO (Beijing
122
China). TC and TG assay kits were the products of Biosino Bio-technology and
123
Science Inc. (Beijing, China). All reagents used in this study were of analytical grade.
124
Preparation of the Fucoidan
125
The crude fucoidan was purified by an anion exchange column Q-SepharoseTM Fast
126
Flow (2.6 × 30 cm). This column was connected to an ÄKTA FPLC system and
127
eluted with a linear gradient of 0-2 mol·L-1 NaCl. In this study, the fraction containing
128
the highest content of fucose was concentrated, dialyzed against distilled water, and
129
then further purified on a Sephacryl S200HR column (2.6 × 90 cm) with 0.2 mol·L-1
130
NH4HCO3 as the eluent. Sugar-containing fractions were concentrated and freeze-
131
dried for further investigation.19,20
132
Component Analysis of the Fucoidan
133
Carbohydrate content was detected by the phenol-sulfuric acid with fucose as the
134
standard.21 Sulfate ester content was determined according to the method previously
135
reported.22 Protein content was quantified by a BCA assay kit from CWBIO (Beijing
136
China).
137
Monosaccharide Component Analysis
138
The monosaccharides obtained after complete acid hydrolysis by 2.0 mol/L
139
trifluoroacetic acid were pre-column derivatized by PMP. The derivative products 6
ACS Paragon Plus Environment
Page 6 of 35
Page 7 of 35
Journal of Agricultural and Food Chemistry
140
were determined by an Agilent Eclipse XDB-C18 column (5 μm, 4.6×250 mm)
141
connected to a high performance liquid chromatography (HPLC) system.23-26 The
142
flow phase was freshly prepared phosphate buffer saline (PBS, 0.1 M, pH=6.7) and
143
acetonitrile in a ratio of 83: 17 (v/v), and the flow rate was 1.0 mL/min.
144
Monosaccharide composition was determined by comparison with reference sugars
145
(L-rhamnose, L-fucose, D-xylose, D-mannose, D-galactose, D-glucose, D-glucuronic
146
acid and D-glucosamine). Calculation of the molar ratio of the monosaccharide was
147
performed based on the peak area of the reference sugars.
148
Purity and Molecular Weight Determination
149
Purity and molecular weight were determined by high performance gel permeation
150
chromatography (HPGPC) with a RID-10A refractive index detector (Shimadzu,
151
Japan) and a TOSOH TSKgel G4000PWXL column (7.8 × 300 mm) eluting with 0.1
152
M Na2SO4. The flow rate of the mobile phase was 1.0 mL/min, and the column was
153
maintained at 40 °C by a temperature-controlled cabinet. The molecular weight was
154
calculated according to the standard curve made by dextran standards combined with
155
GPC software.26-28
156
FTIR Spectroscopy Analysis
157
The FTIR spectrum of the polysaccharide was recorded on a Thermo Scientific
158
Nicolet iS10 spectrometer. The preparation process was the same as we previously
159
reported.20,28
160
Animals
161
Twenty-five C57BL/6J mice (male, 22 ± 2 g body weight) were purchased from
162
Beijing HFK Bioscience Co., Ltd. (license number: SCXK2014-0004). All7
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
163
experiments were approved by the Laboratory Animal Ethical Committee of Weifang
164
Medical University and followed the NIH Guidelines for the Care and Use of Animals.
165
After acclimatization for 1week, the mice were randomly divided into four groups:
166
the chow diet group (n = 5, water by gavage), the model group (n = 5, water by
167
gavage), the fenofibrate group (n = 5, 50 mg/kg/d by gavage), the low-dose fucoidan
168
A2 group (n = 5, An 50, 50 mg/kg/d by gavage) and the high-dose fucoidan A2 group
169
(n = 5, An200, 200 mg/kg/d by gavage).29,30 Mice were fed a high-fat diet (21% fat
170
and 0.15% cholesterol) for 6 weeks except the chow diet group.
171
Plasma Analysis
172
TC, TG and HDL-C levels in the plasma were measured using commercially available
173
assay kits of Biosino Bio-technology and Science Inc. (Beijing, China) according to
174
the instructions.
175
Protein Isolation, Electrophoresis, and Western Blotting
176
Total proteins from the mice liver or small intestine were extracted using RIPA lysis
177
buffer with complete protease inhibitor according to the manufacturer’s instructions.
178
Equal amounts of protein were subjected to 6 % or 12 % SDS-PAGE and transferred
179
onto Polyvinylidene fluoride membranes by electroblotting as we previously
180
reported.28-31 Images were captured by Clinx ChemiScope 6000 pro (Shanghai, China),
181
and densitometry analysis was conducted using Clinx Image Analysis Software
182
(Shanghai, China). The expression of the proteins was normalized by housekeeping
183
protein β-actin.
184
Data Analysis
8
ACS Paragon Plus Environment
Page 8 of 35
Page 9 of 35
Journal of Agricultural and Food Chemistry
185
All the bioassay results were expressed as the mean ± standard deviation (SD) for at
186
least three independent experiments. Statistical analysis was performed using one-way
187
analysis of variance (ANOVA) followed by Tukey’s test. Differences were
188
considered to be significant at a P